Bio-Techne
TECH
$64.28
Share price
2.59%
Change (1 day)
-18.35%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Number of shares outstanding for Bio-Techne (TECH)
Number of shares outstanding as of April 2024 : 157,533,000
According to Bio-Techne's latest financial reports and stock price the company's current number of shares outstanding is 157,533,000. At the end of 2023 the company had 157,533,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Bio-Techne from 2022 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 0.15 B | 0.33% |
| 2022 | 0.15 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 387,000,000 | 145.66% | 🇺🇸 USA |
 Becton Dickinson BDX | 290,113,000 | 84.16% | 🇺🇸 USA |
 General Electric GE | 1,088,000,000 | 590.65% | 🇺🇸 USA |
 Danaher DHR | 739,800,000 | 369.62% | 🇺🇸 USA |
 Qiagen QGEN | 221,356,672 | 40.51% | 🇳🇱 Netherlands |
 Enzo Biochem ENZ | 50,490,000 | -67.95% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | 29,102,000 | -81.53% | 🇺🇸 USA |